Generex Biotechnology Corp – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from 8-K 10 pages Registration Rights Agreement

from 8-K 4 pages Form of Series D Warrant

from 8-K 4 pages Form of Series C Warrant

from 8-K 4 pages Form of Series B Warrant

from 8-K 4 pages Form of Series a Warrant

from 8-K 3 pages Background

from 8-K 5 pages Common Stock Purchase Warrant Generex Biotechnology Corporation

from 8-K 5 pages Convertible Promissory Note

from 8-K 22 pages Securities Purchase Agreement

from 8-K 3 pages Registration Rights Agreement

from 8-K 4 pages Common Stock Purchase Warrant Generex Biotechnology Corporation

from 8-K 3 pages Convertible Promissory Note

from 8-K 3 pages Securities Purchase Agreement

from 8-K 8 pages Note Due November 26, 2019

from 8-K 37 pages Securities Purchase Agreement

from 8-K 8 pages Form of Warrant to Purchase Common Stock

from 8-K 3 pages Note Due October 26, 2019

from 8-K 5 pages Securities Purchase Agreement

from 8-K ~5 pages Confidential Amendment to Securities Purchase Agreement This Amendment (This “Amendment”) Is Made as of This Day of June, 2018 by and Between: Generex Biotechnology Corporation (The “Company”) -And- Pharma Trials, LLC

from 8-K 18 pages Registration Rights Agreement